Curated News
By: NewsRamp Editorial Staff
September 08, 2025
Neuroplastic Pain Breakthrough: New Therapy Revolutionizes Chronic Treatment
TLDR
- The ATNS conference offers medical professionals cutting-edge Neuroplastic Recovery Therapy techniques to gain an advantage in treating 40% of patients with unexplained symptoms.
- Neuroplastic symptoms result from stress-induced neural pathway changes, and ATNS promotes evidence-based Neuroplastic Recovery Therapy that uncovers stress patterns for healing without invasive procedures.
- ATNS advances neuroplastic pain treatment to reduce suffering for millions, making healthcare more accessible and effective while addressing the chronic pain epidemic.
- Discover how stress rewires the brain to cause real pain, and learn groundbreaking techniques to reverse it at the ATNS conference in Boulder.
Impact - Why it Matters
This development matters because neuroplastic conditions affect approximately 40% of adults who seek medical care, representing millions suffering from chronic pain conditions that traditional medicine often fails to address effectively. The shift toward understanding stress-induced neural pathway changes could transform how we approach fibromyalgia, migraines, IBS, and long COVID—conditions that cost billions in healthcare spending and lost productivity annually. For patients who have exhausted conventional treatments, this evidence-based approach offers hope for recovery without invasive procedures or lifelong medication dependency, potentially reducing healthcare costs while improving quality of life for countless individuals.
Summary
The Association for the Treatment of Neuroplastic Symptoms (ATNS) is hosting a groundbreaking national conference in Boulder, Colorado from September 28-30, 2025, bringing together medical professionals, researchers, and mental health experts to explore cutting-edge approaches to diagnosing and treating neuroplastic symptoms. Led by ATNS President Dr. David Clarke, the conference will feature more than 40 leading experts presenting the first-ever national survey revealing that nearly half of US adults experience unexplained pain or illness that doesn't respond to traditional treatments, with neuroplastic symptoms likely affecting the majority of this group.
The conference will showcase Neuroplastic Recovery Therapy, an evidence-based biopsychosocial approach that addresses stress-induced changes in neural pathways rather than structural damage. Unlike conditions caused by disease or injury, neuroplastic symptoms—including fibromyalgia, migraines, irritable bowel syndrome, chronic back pain, and many long COVID cases—are learned responses to stress, trauma, and adversity that often begin in childhood. The ATNS, a 501(c)(3) nonprofit organization, promotes this safer, more affordable, and more effective treatment method that enables patients to take control of their symptoms without drugs, surgery, or expensive procedures.
Dr. Clarke emphasizes that Neuroplastic Recovery Therapy is the only treatment backed by gold standard science from randomized trials published in top medical journals. The conference represents a significant shift in understanding chronic pain management, focusing on uncovering stress, trauma, and unrecognized emotions to facilitate healing. Medical professionals and researchers can register for the conference through the official event page, while media representatives can contact info@symptomatic.me for press passes to cover this important medical advancement.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Neuroplastic Pain Breakthrough: New Therapy Revolutionizes Chronic Treatment
